A team of researchers from the American University of Cornell announced the effectiveness of the antibiotic «Riverpine) by 99.9% against the bacteria of the legendis, which causes typhoid fever, which paves the way for more effective treatment of this disease that leads to the lives of thousands annually.
In publishing their study results, the researchers stated that more than 99.4% of the isolated clinical samples of the bacteria /s. Typhi/ is still sensitive to antibiotics, “Riverpine” and “Azithromycin”, to increase the percentage for “Riverbin” specifically to 99.91%, which opens the door for the use of “Riverpine” to treat other bacterial diseases, such as bacterial pneumonia and meningitis, pointing out that their research has proven the possibility of resistance to resistance Bacteria /s. Typhi/ for this antibiotic is very low, as it does not exceed one condition in every 1000 injuries.
“Our results show that” Riverpine “may be an effective option in treating severe cases of typhoid fever, especially those resulting from strains resistant to several drugs, and we hope that these results will contribute to expanding the treatment options available in the most affected countries,” said that our results will be an effective option in treating severe cases The protective “capsule” that surrounds bacteria, known as VI, which usually helps it evade the immune system.
“Rivambin” is an accredited drug from the American Food and Drug Administration, and is included in the World Health Organization for Basic Medicines, and is currently used to treat diseases such as travelers diarrhea, and the study indicates the possibility of using it to treat “typhoid” fever.
